These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3750449)

  • 1. [Use of the Port-a-cath subcutaneous central venous catheter in patients with malignant blood diseases].
    la Cour Petersen E; Husegaard HC
    Ugeskr Laeger; 1986 Jun; 148(27):1672-5. PubMed ID: 3750449
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of sulfinpyrazone(Anturan) on the uric acid metabolism in malignant blood diseases].
    de Carvalho RI; Givisiez AN; Cardoso JR
    Hospital (Rio J); 1969 Apr; 75(4):1343-55. PubMed ID: 5306426
    [No Abstract]   [Full Text] [Related]  

  • 3. Port-A-Cath insertions in acute leukemia: does thrombocytopenia affect morbidity?
    Loh AH; Chui CH
    J Pediatr Surg; 2007 Jul; 42(7):1180-4. PubMed ID: 17618877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A subcutaneously implantable catheter in hematologic malignancy--a comparison with a conventional central venous catheter].
    Engervall P; Björkholm M; Backman L; Spira J; Lindquist G; Wetterlöv C
    Lakartidningen; 1988 Sep; 85(36):2839-42. PubMed ID: 3059105
    [No Abstract]   [Full Text] [Related]  

  • 5. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
    Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A
    Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications during treatment of blood diseases with corticosteroid hormonal preparations].
    Latysh VN; Khludeev NI
    Sov Med; 1974 Jun; 37(6):91-5. PubMed ID: 4527064
    [No Abstract]   [Full Text] [Related]  

  • 7. [Safety and effectiveness of central vein catheters indwelling with subcutaneous port in patients undergoing chemotherapy].
    Ge F; Cang J; Xue ZG
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2331-4. PubMed ID: 19087693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of hematologic diseases using androgens].
    Sánchez-Medal L
    Munch Med Wochenschr; 1971 Jun; 113(25):960-5. PubMed ID: 5108720
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombosis of the superior vena cava and auxiliary branches in patients with indwelling catheterization of the internal jugular vein.
    Li H; Wang SX; Wang W; Xu C; Shen S; Yu L; Zhang GZ
    Chin Med J (Engl); 2009 Mar; 122(6):692-6. PubMed ID: 19323936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
    Havemann K; Schmidt M; Malchow H; Sodomann CP
    Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
    [No Abstract]   [Full Text] [Related]  

  • 11. Dual lumen catheters for angioaccess in patients with leukemia.
    Reed WP; Newman KA; Schimpff SC; de Jongh CA; Wiernik PH
    Am Surg; 1983 Jul; 49(7):373-8. PubMed ID: 6614656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fosfomycin in a hematology department].
    Dinelli CA; Montrasio PL; Tansini G
    Minerva Med; 1978 Dec; 69(59):4111-4. PubMed ID: 740308
    [No Abstract]   [Full Text] [Related]  

  • 13. [A central venous catheter of the Hickman type used in patients with hematological diseases].
    Worning AM; Petersen FB; Frimodt-Møller C; Hippe E
    Ugeskr Laeger; 1985 Aug; 147(35):2753-5. PubMed ID: 4071712
    [No Abstract]   [Full Text] [Related]  

  • 14. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Androgens in hematology].
    Sanchez-Medal L
    Cah Med; 1971 May; 12(7):515-22. PubMed ID: 5562270
    [No Abstract]   [Full Text] [Related]  

  • 16. [Complications of central venous catheterization in hematologic patients--prospective study of 193 catheterizations].
    Faber E; Mociková K; Grochal B; Koróny S; Matecek L
    Vnitr Lek; 1994 Dec; 40(12):765-9. PubMed ID: 7839628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of chronic hemoblastosis with new cytostatic agents].
    Quattrin N
    Minerva Med; 1966 Mar; 57(25):1141-3. PubMed ID: 5932017
    [No Abstract]   [Full Text] [Related]  

  • 18. Scheme for creating a subcutaneous tunnel to place an indwelling implantable central venous access system in the forearm.
    Yamamoto K; Tanikake M; Arimoto H; Utsunomiya K; Narabayashi I; Narumi Y
    Cardiovasc Intervent Radiol; 2008; 31(6):1215-8. PubMed ID: 18546039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
    Ng F; Mastoroudes H; Paul E; Davies N; Tibballs J; Hochhauser D; Mayer A; Begent R; Meyer T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):551-6. PubMed ID: 17517500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Placing central lines in patients with implantable (port-a-cath) systems].
    Tornero Tornero JC; Gomar Sancho C
    Rev Esp Anestesiol Reanim; 2002 Dec; 49(10):561-2. PubMed ID: 12677981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.